Cargando…

High Mobility Group Box-1 and Blood–Brain Barrier Disruption

Increasing evidence suggests that inflammatory responses are involved in the progression of brain injuries induced by a diverse range of insults, including ischemia, hemorrhage, trauma, epilepsy, and degenerative diseases. During the processes of inflammation, disruption of the blood–brain barrier (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishibori, Masahiro, Wang, Dengli, Ousaka, Daiki, Wake, Hidenori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764171/ https://www.ncbi.nlm.nih.gov/pubmed/33321691 http://dx.doi.org/10.3390/cells9122650

Ejemplares similares

Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats
por: Wang, Dengli, et al.
Publicado: (2017)

Histamine induced high mobility group box-1 release from vascular endothelial cells through H(1) receptor
por: Gao, Shangze, et al.
Publicado: (2022)

Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats
por: Haruma, Jun, et al.
Publicado: (2016)

Histidine-Rich Glycoprotein Inhibits High-Mobility Group Box-1-Mediated Pathways in Vascular Endothelial Cells through CLEC-1A
por: Gao, Shangze, et al.
Publicado: (2020)

Pretreatment with High Mobility Group Box-1 Monoclonal Antibody Prevents the Onset of Trigeminal Neuropathy in Mice with a Distal Infraorbital Nerve Chronic Constriction Injury
por: Kochi, Takahiro, et al.
Publicado: (2021)

High Mobility Group Box 1 Expression in Oral Inflammation and Regeneration
por: Yamashiro, Keisuke, et al.
Publicado: (2020)

Is hemolysis a novel therapeutic target in COVID-19?
por: Ousaka, Daiki, et al.
Publicado: (2022)

Histidine‐rich glycoprotein augments natural killer cell function by modulating PD‐1 expression via CLEC‐1B
por: Nishimura, Yoshito, et al.
Publicado: (2019)

Histidine‐rich glycoprotein ameliorates endothelial barrier dysfunction through regulation of NF‐κB and MAPK signal pathway
por: Gao, Shangze, et al.
Publicado: (2019)

Treatment of Marmoset Intracerebral Hemorrhage with Humanized Anti-HMGB1 mAb
por: Wang, Dengli, et al.
Publicado: (2022)

HMGB1 Translocation in Neurons after Ischemic Insult: Subcellular Localization in Mitochondria and Peroxisomes
por: Wang, Dengli, et al.
Publicado: (2020)

Corticosterone Induces HMGB1 Release in Primary Cultured Rat Cortical Astrocytes: Involvement of Pannexin-1 and P2X7 Receptor-Dependent Mechanisms
por: Hisaoka-Nakashima, Kazue, et al.
Publicado: (2020)

Leukocyte‐Derived High‐Mobility Group Box 1 Governs Hepatic Immune Responses to Listeria monocytogenes
por: Volmari, Annika, et al.
Publicado: (2021)

Neuropathic Pain in Rats with a Partial Sciatic Nerve Ligation Is Alleviated by Intravenous Injection of Monoclonal Antibody to High Mobility Group Box-1
por: Nakamura, Yoki, et al.
Publicado: (2013)

Histidine-rich glycoprotein as an excellent biomarker for sepsis and beyond
por: Nishibori, Masahiro, et al.
Publicado: (2018)

Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice
por: Watanabe, Haruki, et al.
Publicado: (2017)

Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice
por: Nosaka, Nobuyuki, et al.
Publicado: (2015)

Anti-high mobility group box 1 monoclonal antibody suppressed hyper-permeability and cytokine production in human pulmonary endothelial cells infected with influenza A virus
por: Namba, Takahiro, et al.
Publicado: (2021)

LPS Primes Brain Responsiveness to High Mobility Group Box-1 Protein
por: Peek, Verena, et al.
Publicado: (2021)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

High-Mobility Group Box 1 Disrupts Metabolic Function with Cigarette Smoke Exposure in a Ceramide-Dependent Manner
por: Taylor, Oliver J., et al.
Publicado: (2017)

Potential therapeutic molecular targets for blood-brain barrier disruption after subarachnoid hemorrhage
por: Kanamaru, Hideki, et al.
Publicado: (2019)

High mobility group box 1: as a 'testament' mediator
por: Maruyama, I, et al.
Publicado: (2005)

The Role of High Mobility Group Box 1 in Innate Immunity
por: Lee, Shin-Ae, et al.
Publicado: (2014)

High Mobility Group Box Protein-1 in Wound Repair
por: Ranzato, Elia, et al.
Publicado: (2012)

High-Mobility Group Box 1 in Dry Eye Inflammation
por: Lema, Carolina, et al.
Publicado: (2018)

The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019)

Role of High-Mobility Group Box-1 in Liver Pathogenesis
por: Khambu, Bilon, et al.
Publicado: (2019)

High Mobility Group Box 1 Protein in Cerebral Thromboemboli
por: Essig, Fabian, et al.
Publicado: (2021)

Urinary and serum levels of high mobility group box 1
por: Nakamura, Toshihiko, et al.
Publicado: (2023)

Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis
por: Chen, Xia, et al.
Publicado: (2017)

Epigenetics in blood–brain barrier disruption
por: Ihezie, Stephanie A., et al.
Publicado: (2021)

Role of Extracellular High-Mobility Group Box-1 as a Therapeutic Target of Gastric Cancer
por: Takaki, Wataru, et al.
Publicado: (2022)

Brain Hypothermic Therapy Dramatically Decreases Elevated Blood Concentrations of High Mobility Group Box 1 in Neonates with Hypoxic-Ischemic Encephalopathy
por: Nakamura, Toshihiko, et al.
Publicado: (2013)

High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway
por: HUANG, WUFENG, et al.
Publicado: (2016)

Identification and Characterization of the Lamprey High-Mobility Group Box 1 Gene
por: Pang, Yue, et al.
Publicado: (2012)

Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer
por: Pang, Xiaoao, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_32veq1nk3jp4qmhh3i7gg0q7vu